585 Ofranergene obadenovec (VB-111) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single-center, single-arm phase II trial

• David E Kleiner,
• Tim F Greten,
• Cecilia Monge,
• Seth M Steinberg,
• Changqing Xie,
• Yuta Myojin,
• Kelley Coffman,
• Bradford J Wood,
• Bernadette Redd,
• Donna M Hrones,
• Elliott B Levy

Affiliations

David E Kleiner

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Tim F Greten

NCI, Center for Cancer Research, Bethesda, Maryland, USA

Cecilia Monge

Aff1 0000 0004 1936 8075grid.48336.3aMedical Oncology Service, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Bethesda MD USA

Seth M Steinberg

2National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Changqing Xie

Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Yuta Myojin

Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Kelley Coffman

Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Bradford J Wood

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center & Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA

Bernadette Redd

Radiology and Imaging Sciences, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

Donna M Hrones

2National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Elliott B Levy

2National Cancer Institute, National Institutes of Health, Bethesda, MD, USA